UPDATE: Goldman Sachs Assumes Repare Therapeutics (RPTX) at Buy
Tweet Send to a Friend
(Updated - March 17, 2022 6:03 AM EDT)
Goldman Sachs analyst Chris Shibutani assumes coverage on Repare Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Chris Shibutani assumes coverage on Repare Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
